In some countries, reimbursement and costs associated with polypharmacy will likely be a challenge related to GLP-1RA plus SGLT2i combination therapy
The body's adaptive mechanisms also kick in over time, potentially reducing the drug's effectiveness if doses are stacked too closely together
(2005, 2010) found increased CSF levels of the endogenous cannabinoid anandamide in untreated PD patients, which were unrelated to the severity of the disease (Pisani et al., 2005) and reversed by chronic dopaminergic replacement (Pisani et al., 2010)
Log In to Patient Portal Available Medications Tirzepatide Dual-action GLP-1 and GIP receptor agonist for weight management
Truncated Glucagon-Like Peptide I, An Insulin-Releasing Hormone From the Distal Gut
Even so, maintaining stable exposure without valley periods is tricky